DongKook Pharma calls extraordinary shareholders meeting on proposed name change to DK Centellian

Bitget2026/10/12 01:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DongKook Pharmaceutical will hold an extraordinary shareholders’ meeting on Nov. 27, 2026.
Shareholders will vote on amending the articles to change the company name to DK Centellian.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKook Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012900140), on October 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DongKook Pharma calls extraordinary shareholders meeting on proposed name change to DK Centellian

You may also like

Crypto prices